Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2017
At a glance
- Drugs Prothrombin complex concentrate (Primary) ; Rivaroxaban (Primary) ; Tranexamic acid (Primary)
- Indications Haemorrhage
- Focus Pharmacodynamics
- Sponsors Janssen Pharmaceuticals
- 06 Nov 2017 Results published in the Journal of Thrombosis and Haemostasis
- 04 Jul 2016 Status changed from recruiting to completed.
- 02 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.